In The News

According to the World Health Organization, at least one-third of all cancer cases are preventable. Year after year, more research confirms that living a healthy lifestyle can reduce the risk of many common. Making healthy choices now can impact cancer risk for years or decades to come. Texas Oncology at Wichita Falls offers up some simple ways to lower risk, like eating right, being active and stopping tobaccoo use.

Dr. Micah Burch of Texas Oncology−Baylor Sammons Cancer Center joined NBC DFW to explain the link between breast implants and a rare form of cancer called anaplastic large cell lymphoma (ALCL).

IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions, is hosting its 6th annual Global Proton Therapy User Meeting from March 17th to March 20th at Texas Center for Proton Therapy.

Dr. Sasha Strain of Texas Oncology−Tyler joined East Texas Live to discuss the importance of awareness and screening in the fight against colon cancer.

Texas Oncology's Guillermo Lazo, M.D. talks with Healthy Magazine about genetic testing and understanding family history and cancer risk. While genetic testing can provide invaluable insight, evaluating cancer risk properly is complicated. Dr. Lazo explains the risks and limitations, counseling options and the differences between tests.

A scalp cooling cap may help prevent hair loss for women going through chemotherapy. Dr. Jay Courtright of Texas Oncology–Medical City Dallas joins NBC DFW to explain how it works.

Gayle Patel, Director of Texas Oncology’s Genetic Risk Evaluation and Testing (GREAT) program, discusses hereditary breast cancer, the BRCA mutation, and answers common questions related to genetic testing.

Dr. Debra Patt, medical oncologist, hematologist, and breast cancer specialist at Texas Oncology–Austin Central, contributed her comments to OncLive’s Oncology Business Management in an article regarding patient data (“Big Data”) and individualized insurance coverage as it relates to cancer care, healthcare costs, and decision-making for employers. 

Dr. Debra Patt, medical oncologist, hematologist, and breast cancer specialist at Texas Oncology–Austin Central, contributed an article to the Austin Business Journal  after participating in a Cancer Moonshot panel on the future of innovation and access to quality cancer care in Washington, D.C. In the article, Dr. Patt describes what Texas Oncology is doing to deliver high-quality, innovative care in a community setting as an example of how Austin physicians can become involved with national initiative.

Breakthroughs in breast cancer treatment have helped create more than 3 million survivors in the U.S. Jennifer Snow, a breast surgeon at Texas Oncology, talks with the Cleburne Times Review about managing metastatic breast cancer. While some women live for many years with this disease, survival rate is only three years on average. It's difficult to talk about recurrence risk, and Dr. Snow says this pink elephant in the room is a profound challenge for patients in the oncology community.